NYtor Email Format
Biotechnology ResearchGelderland, Netherlands2-10 Employees
NYtor is a biotechnology research company that designs and develops smart molecular detection tests in collaboration with a range of partners. The firm emphasizes rapid, field-applicable assays and specializes in quantitative PCR and point-of-care formats, with a focus on identifying pathogens and their antibiotic resistance as well as enabling early cancer screening. Headquartered in Nijmegen, Gelderland, the Netherlands, NYtor operates as a small team working with external partners on assay development. In April 2024, NYtor announced a collaboration with Alveo Technologies to create rapid swine flu assays for the Alveo platform, aimed at enabling real-time pen-side monitoring of prevalent swine influenza strains such as H1N1, H1N2 and H3N2.